Human Papillomavirus-Related Pharyngeal Squamous Cell Carcinoma

Human Papillomavirus-Related Pharyngeal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

54 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 30
Recruiting: 16
Ph III recruiting: 0
Growth YoY: —
Industry share: 17%
Top sponsor: Abramson Cancer Center at Penn Medicine
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (7)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07565740	Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC	recruiting	Phase 1	9	West China HospitalOTHER	1	Sep 22, 2026	clinicaltrials
NCT06016920	Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma	recruiting	Phase 1 / Phase 2	110	Nykode Therapeutics ASAINDUSTRY	7	Aug 26, 2026	clinicaltrials